Sunset Capital Assets (SNST) 주식 개요는 알코올을 사용하지 않는 살균 솔루션을 개발합니다. 자세히 보기SNST 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6위험 분석재무 데이터를 보고하지 않았습니다.의미 있는 시가총액이 없습니다($266K)주식은 유동성이 매우 낮습니다모든 위험 점검 보기SNST Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.001해당 없음내재 할인율Est. Revenue$PastFuture012016201920222025202620282031Revenue US$1.0Earnings US$0.09AdvancedSet Fair ValueView all narrativesSunset Capital Assets, Inc. 경쟁사Titanium Holdings GroupSymbol: OTCPK:TTHGMarket cap: US$1.2mShinecoSymbol: OTCPK:SISIMarket cap: US$249.7kNevis BrandsSymbol: OTCPK:NEVI.FMarket cap: US$840.8kMiami Breeze Car CareSymbol: OTCPK:MIBEMarket cap: US$80.1m가격 이력 및 성과Sunset Capital Assets 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가US$0.00152주 최고가US$0.00152주 최저가US$0.0001베타01개월 변동150.00%3개월 변동n/a1년 변동900.00%3년 변동-86.67%5년 변동-99.90%IPO 이후 변동-99.90%최근 뉴스 및 업데이트공시 • Feb 19Aphex BioCleanse Systems, Inc Suspends Director Scott SmithAphex BioCleanse Systems, Inc. announces it has come to the attention of the Board of Directors of Aphex BioCleanse Systems, Inc., that on February 10, 2022, Board Member Scott Smith filed a legal action in the U.S. District Court for Massachusetts against the Company and two of its Directors. The object of the lawsuit is not to benefit the Company's shareholders but to financially benefit Scott Smith individually, and the litigation potentially damages shareholder interests. This litigation also clearly violates the "Schoon Doctrine", (Schoon v. Smith, No. 554, 2006 Del. Feb. 12, 2008) Accordingly, the Chairman of the Aphex Board of Directors, Thomas Fitzgerald has determined, effective immediately, to suspend Scott Smith from any, and all duties as a Board Director, pending a complete investigation of this matter and allow a review by the other full Board members.공시 • Jun 12Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC.Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC on June 11, 2021. As a part of the transaction, Sunset Capital Assets also acquired a patented Open-Cell Foam technology. The acquired business includes the product line: BioFoam face shields (BioShield), Wipes (BioWipes), Mitts (BioMitt), and Sponges (BioSponge), and a Hand Sanitizer and Surface Cleaner (BioWash). Scott Smith, Inventor of BioFoam will join Sunset Capital Assets as Chief Sustainability Officer. Sunset Capital Assets, Inc. (OTCPK:SNST) completed the acquisition of Business of US BioSolutions LLC on June 11, 2021.공시 • Mar 04Aphex Biocleanse Systems Announces Significant Purchase Order for Proprietary Non-Toxic Disinfecting Wipe AlternativeAphex BioCleanse Systems, Inc. announced that the Company has received a significant initial purchase order ("PO") from eTECH Channel, which has been helping companies build successful sales channels since 2014, for its proprietary Hy-IQ® Water non-toxic disinfecting wipes. eTECH Channel intends to offer Aphex's disinfecting wipes, which were announced last week, to its extensive distribution channel under the name Hy-IQ® Hand Wipes (the "Wipes"). This initial PO is for 4,950 gallons of 10x concentration DermAphex® product and fills requests for several of eTECH Channel's major national retail clients. Hy-IQ® Hand Wipes conform to the FDA monograph for hand disinfecting products that will be available in retail and healthcare facilities through eTECH Channel shortly.공시 • Feb 24Aphex BioCleanse Systems Broadens Offerings to Include Non-Toxic Sanitizing WipesAphex BioCleanse Systems, Inc. announced that the company has broadened its product offerings to include non-toxic sanitizing wipes formulated with its proprietary Hy-IQ® Water technology. Third-party studies have proven Hy-IQ® Water is effective against human coronavirus, swine flu, E. coli, influenza, Candida auris, Candida albicans, MRSA, and several additional pathogens. Hy-IQ® Water achieves these results through physics rather than chemicals, so Aphex sanitizing products are both highly effective and non-toxic. The global disinfectant products market is expected to reach $30.11 billion by 2027 partly due to an increase in demand for sanitizers and disinfectants during the COVID-19 pandemic. This presents a large market opportunity for Aphex's sanitizing wipes, which are the only water-based and non-toxic option on the market. The company will soon be announcing partnerships with several large-scale distributors that would like to offer its sanitizing wipes to their channels and is open to additional opportunities.공시 • Dec 18Aphex Biocleanse Systems Signs European Supply and Private Label Agreement for Dermaphex and Sanaphex ProductsAphex BioCleanse Systems, Inc. announced that the company has signed a supply and private label agreement with Qurexx B.V. ("Qurexx"). As part of the agreement, and following required European registration processes, Qurexx holds the authority to purchase, market and sell Aphex's DermAphex Hand Sanitizer and SanAphex Hard Surface Sanitizer throughout the European Union, the United Kingdom, Switzerland and Eastern Europe. Qurexx will purchase the products directly from Aphex and is expected to place a significant purchase order in the near future following the required European product registration approvals. Through this agreement, Aphex will leverage Qurexx's key partnerships and distribution channels to increase accessibility of the Company's water-based sanitization products across Europe. As part of its European expansion, Aphex has also registered its DermAphex® Hand Sanitizer and SanAphex® Hard Surface Sanitizer in Germany. With this registration, the Company can now begin shipping and selling products in the country.공시 • Nov 13Aphex BioCleanse Systems Appoints Mark Washo as Senior Vice President of Sales and MarketingAphex BioCleanse Systems, Inc. announced that seasoned sports and business marketing executive Mark Washo has joined the Company as Senior Vice President of Sales and Marketing. Prior to joining Aphex, Washo held a number of respected senior marketing positions over the course of almost three decades. In his most recent role, he served as the Chief Business Officer of Marina Auto Stadium and the Rochester Rhinos where he managed the day to day operations of the stadium and professional USL soccer team.더 많은 업데이트 보기Recent updates공시 • Feb 19Aphex BioCleanse Systems, Inc Suspends Director Scott SmithAphex BioCleanse Systems, Inc. announces it has come to the attention of the Board of Directors of Aphex BioCleanse Systems, Inc., that on February 10, 2022, Board Member Scott Smith filed a legal action in the U.S. District Court for Massachusetts against the Company and two of its Directors. The object of the lawsuit is not to benefit the Company's shareholders but to financially benefit Scott Smith individually, and the litigation potentially damages shareholder interests. This litigation also clearly violates the "Schoon Doctrine", (Schoon v. Smith, No. 554, 2006 Del. Feb. 12, 2008) Accordingly, the Chairman of the Aphex Board of Directors, Thomas Fitzgerald has determined, effective immediately, to suspend Scott Smith from any, and all duties as a Board Director, pending a complete investigation of this matter and allow a review by the other full Board members.공시 • Jun 12Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC.Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC on June 11, 2021. As a part of the transaction, Sunset Capital Assets also acquired a patented Open-Cell Foam technology. The acquired business includes the product line: BioFoam face shields (BioShield), Wipes (BioWipes), Mitts (BioMitt), and Sponges (BioSponge), and a Hand Sanitizer and Surface Cleaner (BioWash). Scott Smith, Inventor of BioFoam will join Sunset Capital Assets as Chief Sustainability Officer. Sunset Capital Assets, Inc. (OTCPK:SNST) completed the acquisition of Business of US BioSolutions LLC on June 11, 2021.공시 • Mar 04Aphex Biocleanse Systems Announces Significant Purchase Order for Proprietary Non-Toxic Disinfecting Wipe AlternativeAphex BioCleanse Systems, Inc. announced that the Company has received a significant initial purchase order ("PO") from eTECH Channel, which has been helping companies build successful sales channels since 2014, for its proprietary Hy-IQ® Water non-toxic disinfecting wipes. eTECH Channel intends to offer Aphex's disinfecting wipes, which were announced last week, to its extensive distribution channel under the name Hy-IQ® Hand Wipes (the "Wipes"). This initial PO is for 4,950 gallons of 10x concentration DermAphex® product and fills requests for several of eTECH Channel's major national retail clients. Hy-IQ® Hand Wipes conform to the FDA monograph for hand disinfecting products that will be available in retail and healthcare facilities through eTECH Channel shortly.공시 • Feb 24Aphex BioCleanse Systems Broadens Offerings to Include Non-Toxic Sanitizing WipesAphex BioCleanse Systems, Inc. announced that the company has broadened its product offerings to include non-toxic sanitizing wipes formulated with its proprietary Hy-IQ® Water technology. Third-party studies have proven Hy-IQ® Water is effective against human coronavirus, swine flu, E. coli, influenza, Candida auris, Candida albicans, MRSA, and several additional pathogens. Hy-IQ® Water achieves these results through physics rather than chemicals, so Aphex sanitizing products are both highly effective and non-toxic. The global disinfectant products market is expected to reach $30.11 billion by 2027 partly due to an increase in demand for sanitizers and disinfectants during the COVID-19 pandemic. This presents a large market opportunity for Aphex's sanitizing wipes, which are the only water-based and non-toxic option on the market. The company will soon be announcing partnerships with several large-scale distributors that would like to offer its sanitizing wipes to their channels and is open to additional opportunities.공시 • Dec 18Aphex Biocleanse Systems Signs European Supply and Private Label Agreement for Dermaphex and Sanaphex ProductsAphex BioCleanse Systems, Inc. announced that the company has signed a supply and private label agreement with Qurexx B.V. ("Qurexx"). As part of the agreement, and following required European registration processes, Qurexx holds the authority to purchase, market and sell Aphex's DermAphex Hand Sanitizer and SanAphex Hard Surface Sanitizer throughout the European Union, the United Kingdom, Switzerland and Eastern Europe. Qurexx will purchase the products directly from Aphex and is expected to place a significant purchase order in the near future following the required European product registration approvals. Through this agreement, Aphex will leverage Qurexx's key partnerships and distribution channels to increase accessibility of the Company's water-based sanitization products across Europe. As part of its European expansion, Aphex has also registered its DermAphex® Hand Sanitizer and SanAphex® Hard Surface Sanitizer in Germany. With this registration, the Company can now begin shipping and selling products in the country.공시 • Nov 13Aphex BioCleanse Systems Appoints Mark Washo as Senior Vice President of Sales and MarketingAphex BioCleanse Systems, Inc. announced that seasoned sports and business marketing executive Mark Washo has joined the Company as Senior Vice President of Sales and Marketing. Prior to joining Aphex, Washo held a number of respected senior marketing positions over the course of almost three decades. In his most recent role, he served as the Chief Business Officer of Marina Auto Stadium and the Rochester Rhinos where he managed the day to day operations of the stadium and professional USL soccer team.공시 • Oct 13Aphex BioCleanse Systems, Inc. Announces Management AppointmentsAphex BioCleanse Systems, Inc. announced that Kevin Harrington and Mark Timm have joined the Company as advisors. Harrington joins Aphex at a key moment in the Company's growth as sanitization products are in high demand due to the global COVID-19 pandemic. The hand sanitizer market alone, which includes Aphex's alcohol-free hand sanitizer DermAphex®, is expected to see a compound annual growth rate (CAGR) of almost 46% in 2020. Throughout his career, Harrington has worked behind the scenes of business ventures and produced more than $5 billion in global sales. He has assisted in the successful launch of more than 500 products, in making dozens of millionaires and has been responsible for the launch of more than 20 businesses that have each topped $100 million in revenue. He has also been involved with iconic brands and celebrities such as Jack Lalanne, Tony Little, George Foreman. and Kim Kardashian, among others.주주 수익률SNSTUS Household ProductsUS 시장7D0%1.3%2.5%1Y900.0%-15.3%26.4%전체 주주 수익률 보기수익률 대 산업: SNST은 지난 1년 동안 -15.3%의 수익을 기록한 US Household Products 산업보다 더 좋은 성과를 냈습니다.수익률 대 시장: SNST은 지난 1년 동안 26.4%를 기록한 US 시장보다 더 좋은 성과를 냈습니다.주가 변동성Is SNST's price volatile compared to industry and market?SNST volatilitySNST Average Weekly Movementn/aHousehold Products Industry Average Movement3.5%Market Average Movement7.2%10% most volatile stocks in US Market16.5%10% least volatile stocks in US Market3.1%안정적인 주가: SNST의 주가는 지난 3개월 동안 US 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine SNST의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트2010n/an/awww.aphexus.com는 알코올을 사용하지 않는 살균 솔루션을 개발하는 회사입니다. 이 회사의 제품에는 소독제, 표면 소독제, 상처 세척제, 가축 치료용 솔루션이 포함됩니다. 이 회사는 2010년에 설립되었으며 뉴욕주 로체스터에 본사를 두고 있습니다.더 보기Sunset Capital Assets, Inc. 기초 지표 요약Sunset Capital Assets의 순이익과 매출은 시가총액과 어떻게 비교됩니까?SNST 기초 통계시가총액US$265.92k순이익 (TTM)US$0매출 (TTM)n/an/a주가수익비율(P/E)n/a주가매출비율(P/S)SNST는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표SNST 손익계산서 (TTM)매출US$0매출원가US$0총이익US$0기타 비용US$0순이익US$0최근 보고된 실적해당 없음다음 실적 발표일해당 없음주당순이익(EPS)0총이익률0.00%순이익률0.00%부채/자본 비율0.0%SNST의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/27 17:22종가2026/05/19 00:00수익N/A연간 수익N/A데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Sunset Capital Assets, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Feb 19Aphex BioCleanse Systems, Inc Suspends Director Scott SmithAphex BioCleanse Systems, Inc. announces it has come to the attention of the Board of Directors of Aphex BioCleanse Systems, Inc., that on February 10, 2022, Board Member Scott Smith filed a legal action in the U.S. District Court for Massachusetts against the Company and two of its Directors. The object of the lawsuit is not to benefit the Company's shareholders but to financially benefit Scott Smith individually, and the litigation potentially damages shareholder interests. This litigation also clearly violates the "Schoon Doctrine", (Schoon v. Smith, No. 554, 2006 Del. Feb. 12, 2008) Accordingly, the Chairman of the Aphex Board of Directors, Thomas Fitzgerald has determined, effective immediately, to suspend Scott Smith from any, and all duties as a Board Director, pending a complete investigation of this matter and allow a review by the other full Board members.
공시 • Jun 12Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC.Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC on June 11, 2021. As a part of the transaction, Sunset Capital Assets also acquired a patented Open-Cell Foam technology. The acquired business includes the product line: BioFoam face shields (BioShield), Wipes (BioWipes), Mitts (BioMitt), and Sponges (BioSponge), and a Hand Sanitizer and Surface Cleaner (BioWash). Scott Smith, Inventor of BioFoam will join Sunset Capital Assets as Chief Sustainability Officer. Sunset Capital Assets, Inc. (OTCPK:SNST) completed the acquisition of Business of US BioSolutions LLC on June 11, 2021.
공시 • Mar 04Aphex Biocleanse Systems Announces Significant Purchase Order for Proprietary Non-Toxic Disinfecting Wipe AlternativeAphex BioCleanse Systems, Inc. announced that the Company has received a significant initial purchase order ("PO") from eTECH Channel, which has been helping companies build successful sales channels since 2014, for its proprietary Hy-IQ® Water non-toxic disinfecting wipes. eTECH Channel intends to offer Aphex's disinfecting wipes, which were announced last week, to its extensive distribution channel under the name Hy-IQ® Hand Wipes (the "Wipes"). This initial PO is for 4,950 gallons of 10x concentration DermAphex® product and fills requests for several of eTECH Channel's major national retail clients. Hy-IQ® Hand Wipes conform to the FDA monograph for hand disinfecting products that will be available in retail and healthcare facilities through eTECH Channel shortly.
공시 • Feb 24Aphex BioCleanse Systems Broadens Offerings to Include Non-Toxic Sanitizing WipesAphex BioCleanse Systems, Inc. announced that the company has broadened its product offerings to include non-toxic sanitizing wipes formulated with its proprietary Hy-IQ® Water technology. Third-party studies have proven Hy-IQ® Water is effective against human coronavirus, swine flu, E. coli, influenza, Candida auris, Candida albicans, MRSA, and several additional pathogens. Hy-IQ® Water achieves these results through physics rather than chemicals, so Aphex sanitizing products are both highly effective and non-toxic. The global disinfectant products market is expected to reach $30.11 billion by 2027 partly due to an increase in demand for sanitizers and disinfectants during the COVID-19 pandemic. This presents a large market opportunity for Aphex's sanitizing wipes, which are the only water-based and non-toxic option on the market. The company will soon be announcing partnerships with several large-scale distributors that would like to offer its sanitizing wipes to their channels and is open to additional opportunities.
공시 • Dec 18Aphex Biocleanse Systems Signs European Supply and Private Label Agreement for Dermaphex and Sanaphex ProductsAphex BioCleanse Systems, Inc. announced that the company has signed a supply and private label agreement with Qurexx B.V. ("Qurexx"). As part of the agreement, and following required European registration processes, Qurexx holds the authority to purchase, market and sell Aphex's DermAphex Hand Sanitizer and SanAphex Hard Surface Sanitizer throughout the European Union, the United Kingdom, Switzerland and Eastern Europe. Qurexx will purchase the products directly from Aphex and is expected to place a significant purchase order in the near future following the required European product registration approvals. Through this agreement, Aphex will leverage Qurexx's key partnerships and distribution channels to increase accessibility of the Company's water-based sanitization products across Europe. As part of its European expansion, Aphex has also registered its DermAphex® Hand Sanitizer and SanAphex® Hard Surface Sanitizer in Germany. With this registration, the Company can now begin shipping and selling products in the country.
공시 • Nov 13Aphex BioCleanse Systems Appoints Mark Washo as Senior Vice President of Sales and MarketingAphex BioCleanse Systems, Inc. announced that seasoned sports and business marketing executive Mark Washo has joined the Company as Senior Vice President of Sales and Marketing. Prior to joining Aphex, Washo held a number of respected senior marketing positions over the course of almost three decades. In his most recent role, he served as the Chief Business Officer of Marina Auto Stadium and the Rochester Rhinos where he managed the day to day operations of the stadium and professional USL soccer team.
공시 • Feb 19Aphex BioCleanse Systems, Inc Suspends Director Scott SmithAphex BioCleanse Systems, Inc. announces it has come to the attention of the Board of Directors of Aphex BioCleanse Systems, Inc., that on February 10, 2022, Board Member Scott Smith filed a legal action in the U.S. District Court for Massachusetts against the Company and two of its Directors. The object of the lawsuit is not to benefit the Company's shareholders but to financially benefit Scott Smith individually, and the litigation potentially damages shareholder interests. This litigation also clearly violates the "Schoon Doctrine", (Schoon v. Smith, No. 554, 2006 Del. Feb. 12, 2008) Accordingly, the Chairman of the Aphex Board of Directors, Thomas Fitzgerald has determined, effective immediately, to suspend Scott Smith from any, and all duties as a Board Director, pending a complete investigation of this matter and allow a review by the other full Board members.
공시 • Jun 12Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC.Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC on June 11, 2021. As a part of the transaction, Sunset Capital Assets also acquired a patented Open-Cell Foam technology. The acquired business includes the product line: BioFoam face shields (BioShield), Wipes (BioWipes), Mitts (BioMitt), and Sponges (BioSponge), and a Hand Sanitizer and Surface Cleaner (BioWash). Scott Smith, Inventor of BioFoam will join Sunset Capital Assets as Chief Sustainability Officer. Sunset Capital Assets, Inc. (OTCPK:SNST) completed the acquisition of Business of US BioSolutions LLC on June 11, 2021.
공시 • Mar 04Aphex Biocleanse Systems Announces Significant Purchase Order for Proprietary Non-Toxic Disinfecting Wipe AlternativeAphex BioCleanse Systems, Inc. announced that the Company has received a significant initial purchase order ("PO") from eTECH Channel, which has been helping companies build successful sales channels since 2014, for its proprietary Hy-IQ® Water non-toxic disinfecting wipes. eTECH Channel intends to offer Aphex's disinfecting wipes, which were announced last week, to its extensive distribution channel under the name Hy-IQ® Hand Wipes (the "Wipes"). This initial PO is for 4,950 gallons of 10x concentration DermAphex® product and fills requests for several of eTECH Channel's major national retail clients. Hy-IQ® Hand Wipes conform to the FDA monograph for hand disinfecting products that will be available in retail and healthcare facilities through eTECH Channel shortly.
공시 • Feb 24Aphex BioCleanse Systems Broadens Offerings to Include Non-Toxic Sanitizing WipesAphex BioCleanse Systems, Inc. announced that the company has broadened its product offerings to include non-toxic sanitizing wipes formulated with its proprietary Hy-IQ® Water technology. Third-party studies have proven Hy-IQ® Water is effective against human coronavirus, swine flu, E. coli, influenza, Candida auris, Candida albicans, MRSA, and several additional pathogens. Hy-IQ® Water achieves these results through physics rather than chemicals, so Aphex sanitizing products are both highly effective and non-toxic. The global disinfectant products market is expected to reach $30.11 billion by 2027 partly due to an increase in demand for sanitizers and disinfectants during the COVID-19 pandemic. This presents a large market opportunity for Aphex's sanitizing wipes, which are the only water-based and non-toxic option on the market. The company will soon be announcing partnerships with several large-scale distributors that would like to offer its sanitizing wipes to their channels and is open to additional opportunities.
공시 • Dec 18Aphex Biocleanse Systems Signs European Supply and Private Label Agreement for Dermaphex and Sanaphex ProductsAphex BioCleanse Systems, Inc. announced that the company has signed a supply and private label agreement with Qurexx B.V. ("Qurexx"). As part of the agreement, and following required European registration processes, Qurexx holds the authority to purchase, market and sell Aphex's DermAphex Hand Sanitizer and SanAphex Hard Surface Sanitizer throughout the European Union, the United Kingdom, Switzerland and Eastern Europe. Qurexx will purchase the products directly from Aphex and is expected to place a significant purchase order in the near future following the required European product registration approvals. Through this agreement, Aphex will leverage Qurexx's key partnerships and distribution channels to increase accessibility of the Company's water-based sanitization products across Europe. As part of its European expansion, Aphex has also registered its DermAphex® Hand Sanitizer and SanAphex® Hard Surface Sanitizer in Germany. With this registration, the Company can now begin shipping and selling products in the country.
공시 • Nov 13Aphex BioCleanse Systems Appoints Mark Washo as Senior Vice President of Sales and MarketingAphex BioCleanse Systems, Inc. announced that seasoned sports and business marketing executive Mark Washo has joined the Company as Senior Vice President of Sales and Marketing. Prior to joining Aphex, Washo held a number of respected senior marketing positions over the course of almost three decades. In his most recent role, he served as the Chief Business Officer of Marina Auto Stadium and the Rochester Rhinos where he managed the day to day operations of the stadium and professional USL soccer team.
공시 • Oct 13Aphex BioCleanse Systems, Inc. Announces Management AppointmentsAphex BioCleanse Systems, Inc. announced that Kevin Harrington and Mark Timm have joined the Company as advisors. Harrington joins Aphex at a key moment in the Company's growth as sanitization products are in high demand due to the global COVID-19 pandemic. The hand sanitizer market alone, which includes Aphex's alcohol-free hand sanitizer DermAphex®, is expected to see a compound annual growth rate (CAGR) of almost 46% in 2020. Throughout his career, Harrington has worked behind the scenes of business ventures and produced more than $5 billion in global sales. He has assisted in the successful launch of more than 500 products, in making dozens of millionaires and has been responsible for the launch of more than 20 businesses that have each topped $100 million in revenue. He has also been involved with iconic brands and celebrities such as Jack Lalanne, Tony Little, George Foreman. and Kim Kardashian, among others.
